Address: Camino A Melipilla Nº 7073 – Cerrillos, Santiago,Chile
Tel: +56 2 483 1600
Web: http://www.farmindustria.cl/
Farmindustria originated in 1998 when Volta Laboratory acquired a production plant belonging to Schering Plough. The manufacturing plant was one of the most technologically-advanced installations in the Chilean pharmaceutical industry and Latin America. The company today has become the leading pharmaceutical contract manufacturer in the country with GMP certification since 2004. Given that they do not have their own product, they describe themselves as a company that specializes in the development, production, packaging, quality control, storage and distribution of products in the national pharmaceutical market.
The company has a pharmaceutical plant with 21,000 m2 of land and more than 6,500 m2 of constructed area. The plant produces more than 18,000,000 units per year, equivalent to over 40% of the total contract manufacturing market in Chile in terms of units. Its installations employ more than 200 people, including more than 30 highly qualified professionals and technicians.
Farmaindustria currently has more than 30 transnational and national laboratories as customers. They include Pfizer, Sanofi-Aventis, Recalcine Medipharm, Medcell, Laboratorios Chile, Galderma, Tecnofarma, Royalpharma, Andromaco, PharmaInvesti, Volta, Prater and Fasa. It also manufactures directly to overseas laboratories and national laboratories who export some of their products directly to their subsidiaries.
As part of its long-term strategy, Farmindustria invests heavily in increasing its production capacity so as to always remain competitive and current. It has developed strategic alliances with several universities and research centers in Chile and abroad in order to be able to produce biotech drugs.
development, production, packaging, quality control, storage and distribution
As the CEO of Farmindustria since 1998, what would you say has been your recipe for the impressive success that the company has experienced, considering that Farmindustria represents 35% of…
Korean biotech SK Bioscience, known for bringing forward the first South Korean-developed COVID-19 vaccine, is pursuing its beyond-COVID growth strategy with a new green light for its SKYCellflu vaccine. The…
Against a backdrop of protests against Chile’s market-dominant socio-economic model, President Sebastián Piñera has announced a wave of reforms to address inequalities and improve treatment within the country’s healthcare system.…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of…
Although Chile is a relatively small market, with only 17 million inhabitants, its geography makes it a challenging environment for logistics and distribution services. Chile stretches over 4,300 km along…
Chile is aiming to achieve complete bioequivalence of generics by the end of 2014. Chile’s Public Health Institute is leading the bioequivalence testing, aimed at regulating differences between generic and…
Elmer Torres Cortes is General Manager of the Industrial Association of Pharmaceutical Laboratories (ASILFA) that was created to defend the interests of the generic and local manufacturers. Cortes speaks about…
“Clinica Alemana’s objective is to be the most patient-centric clinic and we take that very seriously. Therefore, we constantly strive to provide the most modern technology, the best infrastructure and,…
Deutsche Pharma’s general manager, Luis Aguilera, speaks about the company’s long family history and growth ambitions t. Deutsche Pharma commercializes its own brands and acts as distributor, supplying the local…
“A company active in the Chilean pharmaceutical market has to reinvent its business model every three years because today we are competing against some of the largest multinationals.” How…
When Antonio Avila came to Chile in 2011, one of his main goals was to adapt the business model to the current needs of the market. The General Manager of…
The global pharmaceutical sector continues to witness significant mergers and acquisitions activity, with 122 M&A deals completed in 2013. This trend has continued due to several multi-billion dollar deals around the…
Chile witnessed increasing demand for vitamin and dietary supplements as a result of improvement of disposable incomes and living standards. Gerardo Sanchez saw an opportunity in this nice and established…
See our Cookie Privacy Policy Here
